Fabrication Strategies for Bioinspired and Functional Lung‐on‐Chips

Author:

Doryab Ali123ORCID,Braig Johannes3,Jungst Tomasz34,Ryma Matthias35,Groll Jürgen3ORCID

Affiliation:

1. Department of Engineering University of Cambridge Cambridge CB2 1PZ UK

2. The Nanoscience Centre University of Cambridge Cambridge CB3 0FF UK

3. Department of Functional Materials in Medicine and Dentistry Institute of Functional Materials and Biofabrication (IFB) and Bavarian Polymer Institute (BPI) University of Würzburg 97070 Würzburg Germany

4. Department of Orthopedics Regenerative Medicine Center Utrecht University Medical Center Utrecht Utrecht 3584 CX The Netherlands

5. Chair of Biomaterials University of Bayreuth 95447 Bayreuth Germany

Abstract

AbstractLung‐on‐chips (LoCs) are advanced microsystems designed to culture pulmonary cells under physiologically relevant conditions, including air–liquid interface, cell stretch, and shear stress. As the most promising preclinical models, the LoCs are aimed to reduce and ultimately replace conventional ineffective animal studies. Biomimetic and functional LoCs lead to more translational preclinical studies that effectively address unmet needs across therapeutic areas. A variety of cell‐ and scaffold‐based techniques are employed to establish biomimetic pulmonary cell models that closely resemble their in vivo counterparts, which is a challenging yet critical aspect of LoCs. Herein, the challenges encountered in biomimetic LoCs are discussed, and the future perspectives toward higher biomimicry using advanced biofabrication approaches are explored.

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Reference103 articles.

1. The unmet global burden of COPD

2. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline

3. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes http://data.europa.eu/eli/dir/2010/63/oj(accessed: September 2010 amended on September 2019).

4. S.5002 –117th Congress (2021‐2022): FDA Modernization Act 2.0 https://www.congress.gov/bill/117th‐congress/senate‐bill/5002(accessed: September 2022).

5. Is it Time for Reviewer 3 to Request Human Organ Chip Experiments Instead of Animal Validation Studies?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3